Key financial metrics (EUR, QQ4 2025 unless otherwise noted):
- Revenue: Not disclosed in the provided data (N/A).
- Gross Profit: -€1,630,795; Gross Margin: N/A due to missing revenue data; YoY: -408.17% (per earnings metrics), QoQ: -269.53%.
- EBITDA: -€4,097,603; EBITDA margin: N/A (revenue undisclosed).
- Operating Income: -€4,117,375; QoQ: -357.31%; YoY: -134.74%.
- Net Income: -€19,510; QoQ: -100.92%; YoY: -100.16%.
- Depreciation and Amortization: €19,773.
- Interest expense: n/a.
- Income tax expense: €38,280; Income before tax: €18,771.
- Weighted average shares outstanding: 821,822,948.
- Cash flow from operations: -€363,918.
- Capital expenditures (capex): -€50,500.
- Free Cash Flow: -€414,418.
- Net cash provided by/used in financing activities: €834.
- Effect of foreign exchange on cash: €6,967.
- Net change in cash: €14,972,647; Cash at end of period: €14,972,647.
- Balance sheet highlights: Total assets €96,320,798; Cash and equivalents €14,972,647; Total current assets €16,493,111; Total current liabilities €1,963,404; Total liabilities €2,039,992; Total stockholders’ equity €94,280,806; Accumulated other comprehensive income loss €94,923,942; OthertotalStockholdersEquity €-164,809,193; Net debt: €-14,971,834 (net cash).
- Four-quarter trend (selected): 2025-Q4 EBITDA (€-4.10m) and net income (€-19.5k) vs 2024-Q4 EBITDA €12.322m and net income €12.228m; 2025-Q2 EBITDA €1.609m and net income €2.120m; 2025-Q3 EBITDA €0.805m and net income €1.060m; 2025-Q4 shows a substantial earnings deterioration despite liquidity gains.